Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis

Natalizumab Induces Changes of Cerebrospinal Fluid Measures in Multiple Sclerosis

Background: There is a lack of knowledge about the evolution of cerebrospinal fluid (CSF) markers in multiple sclerosis (MS) patients undergoing natalizumab treatment. Aim: We aimed to evaluate the effect of natalizumab on basic inflammatory CSF and MRI measures. Methods: Together, 411 patients were...

Full description

Bibliographic Details
Main Authors: Ranjani Ganapathy Subramanian, Dana Horakova, Manuela Vaneckova, Balazs Lorincz, Jan Krasensky, Eva Kubala Havrdova, Tomas Uher
Format: Article
Language:English
Published: MDPI AG 2021-11-01
Series:Diagnostics
Subjects:
natalizumab
cerebrospinal fluid
brain atrophy
oligoclonal bands
MRI
multiple sclerosis
Online Access:https://www.mdpi.com/2075-4418/11/12/2230

Internet

https://www.mdpi.com/2075-4418/11/12/2230

Similar Items